Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Ruxolitinib Potential treatment - clinical evidence Used to treat other disease Other treatment Jun/02/2021 10 0
Teicoplanin Potential treatment - pre-clinical evidence Experimental Antiviral Mar/06/2021 2 1
Azithromycin Potential treatment - clinical evidence Used to treat other disease Antiviral Feb/26/2021 19 10
Ursolic acid Potential treatment - theoretical effect Natural product Antiviral Nov/04/2020 2 0
Somniferine Potential treatment - theoretical effect Natural product Antiviral Aug/27/2020 1 0
Withanoside V Potential treatment - theoretical effect Natural product Antiviral Aug/27/2020 1 0
Isorientin 4′-O-glucoside 2″-O-p-hydroxybenzoagte Potential treatment - theoretical effect Natural product Antiviral Aug/27/2020 1 0
Vicenin Potential treatment - theoretical effect Natural product Antiviral Aug/27/2020 1 0
Tinocordiside Potential treatment - theoretical effect Natural product Antiviral Aug/27/2020 1 0
Excel (.xslx) CSV (.csv)